Head activator as a potential serum marker for brain tumour analysis
- 31 March 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (2-3), 421-424
- https://doi.org/10.1016/s0959-8049(05)80066-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Head activator acts as an autocrine growth factor for NH15-CA2 cells in the G2/mitosis transition.The EMBO Journal, 1989
- Elevated levels of head activator in human brain tumors and in serum of patients with brain and other neurally derived tumorsJournal of Neuro-Oncology, 1988
- Synthesis of new head‐activator analogues and their application for improved radioimmunoassaysInternational Journal of Peptide and Protein Research, 1987
- The neuropeptide head activator loses its biological acitivity by dimerization.The EMBO Journal, 1986
- The Hydra head activator in human blood circulationFEBS Letters, 1984
- Enzyme‐linked immunosorbent assay for the neuropeptide ‘head activator’European Journal of Biochemistry, 1983
- Isolation and amino acid sequence of a morphogenetic peptide from hydraProceedings of the National Academy of Sciences, 1981
- Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humansNature, 1981
- Human hypothalamus and intestine contain a hydra-neuropeptideNeuroscience Letters, 1980
- A neurohormone from hydra is present in brain and intestine of rat embryosJournal of Neurochemistry, 1977